Abstract:
A percutaneous circulatory support device includes an impeller housing and a primary impeller disposed within the impeller housing. The primary impeller is rotatable relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device. The device further includes a counter impeller disposed within the impeller housing.
Abstract:
The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to minimally invasive endoscopy devices and methods for body lumen access and/or drainage, and devices and methods for creating an open flow passage between two or more body lumens.
Abstract:
Methods and devices for treating a lung are disclosed. The method may include deploying a catheter into an airway of the lung, and discharging a media into the airway through the catheter. The media may be configured to increase elasticity of lung tissue in the vicinity of the airway or occlude the airway.
Abstract:
Methods and devices for treating a lung are disclosed. The method may include deploying a catheter into an airway of the lung, and discharging a media into the airway through the catheter. The media may be configured to increase elasticity of lung tissue in the vicinity of the airway or occlude the airway.
Abstract:
In one aspect, the present disclosure provides microparticles that are configured to release a first drug over a first time period and to release a second drug over a second time period, wherein a lag period of substantially no drug release occurs between the first and second time periods. In other aspects, the present disclosure pertains to the use of such microparticles in delivery systems and methods of treatment. In another aspect, the present disclosure pertains to drug delivery systems that comprising a folded inflatable drug delivery balloon that comprises folds and microparticles positioned within the folds.
Abstract:
In one aspect, the present disclosure provides microparticles that are configured to release a first drug over a first time period and to release a second drug over a second time period, wherein a lag period of substantially no drug release occurs between the first and second time periods. In other aspects, the present disclosure pertains to the use of such microparticles in delivery systems and methods of treatment. In another aspect, the present disclosure pertains to drug delivery systems that comprising a folded inflatable drug delivery balloon that comprises folds and microparticles positioned within the folds.
Abstract:
A medical device may include an inflatable balloon secured to a distal region of a catheter shaft. A blade assembly may extend over and be secured to the inflatable balloon. The blade assembly may include a plurality of blades and at least two rings that are adapted to secure each of the plurality of blades. Each of the rings include an inner surface adapted to be secured to the inflatable balloon and an outer surface. A number of living hinges are formed within the inner surface and the outer surface that cooperate to allow the blade assembly to move between an expanded configuration and a collapsed configuration.
Abstract:
A percutaneous circulatory support device includes a housing and an impeller disposed within the housing. The impeller is rotatable relative to the housing to cause blood to flow through the percutaneous circulatory support device. The device further includes a reservoir disposed within the housing, and the reservoir carries at least one anticoagulant.
Abstract:
A percutaneous circulatory support device includes an impeller disposed within an impeller housing. The impeller is rotatable relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device. The device further includes a liquid carrier carrying a liquid. The liquid carrier is rotatable relative to the impeller housing to cause the liquid to form outwardly extending menisci at a plurality of apertures of the liquid carrier.
Abstract:
The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to devices and methods for establishing a controlled flow or access passage between body lumens.